SPDR S&P Pharmaceuticals ETF Rating $43.91 +1.61 (+3.81%) As of 03:33 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock SPDR S&P Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XPH Aggregate RatingModerate Buy 2.70Holdings in XPH have an aggregate rating of Moderate Buy based on 375 analyst ratings issued in the past year covering 43 companies (99.9% of the portfolio).XPH Aggregate Price Target$43.91High Prediction$43.91Average Prediction$43.91Low Prediction$43.91Holdings in XPH have an aggregate price target of $43.91 and a range of $43.91 to $43.91 covering 43 companies (99.9% of the portfolio).XPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy20 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 43 XPH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.82%ELANElanco Animal Health$10.42+0.0%4.0775 of 5 stars2.43$15.17 45.6%73.78%CORTCorcept Therapeutics$112.48+105.9%3.87 of 5 stars3.00$127.00 12.9%5Analyst ForecastNews CoverageGap UpHigh Trading Volume3.75%ZTSZoetis$164.28+0.7%4.595 of 5 stars3.08$215.90 31.4%12Positive News3.75%TARSTarsus Pharmaceuticals$51.30-0.8%2.7019 of 5 stars3.00$63.67 24.1%73.74%AXSMAxsome Therapeutics$116.98-1.3%4.7486 of 5 stars3.00$167.64 43.3%15Short Interest ↓Gap Down3.71%PRGOPerrigo$28.13+0.2%4.7883 of 5 stars2.25$33.00 17.3%4Short Interest ↓3.68%ITCIIntra-Cellular Therapies$131.91+0.1%3.5554 of 5 stars2.47$106.08 -19.6%15Analyst ForecastNews CoveragePositive News3.68%JNJJohnson & Johnson$166.04+1.4%4.3924 of 5 stars2.56$171.33 3.2%18Positive News3.67%LLYEli Lilly and Company$823.55+0.1%4.8003 of 5 stars2.85$1,009.72 22.6%20Positive News3.62%BMYBristol-Myers Squibb$61.16+1.9%3.8739 of 5 stars2.32$57.86 -5.4%19Short Interest ↑Positive News3.60%PBHPrestige Consumer Healthcare$86.40+1.5%3.5569 of 5 stars2.50$93.33 8.0%63.57%PFEPfizer$25.28+0.3%4.9865 of 5 stars2.63$31.92 26.3%163.56%OGNOrganon & Co.$14.86+2.4%4.755 of 5 stars2.43$20.80 40.0%7Positive News3.54%RPRXRoyalty Pharma$31.25-0.4%4.8329 of 5 stars3.00$41.60 33.1%6Analyst ForecastPositive News3.51%VTRSViatris$8.75+0.7%1.8609 of 5 stars1.75$10.50 20.1%4Short Interest ↑3.46%JAZZJazz Pharmaceuticals$124.42+1.2%4.9079 of 5 stars2.93$187.71 50.9%14Positive News3.44%MRKMerck & Co., Inc.$89.77+0.6%5 of 5 stars2.65$117.12 30.5%233.22%EWTXEdgewise Therapeutics$23.10-0.7%1.9095 of 5 stars2.88$45.38 96.4%8Gap Down2.88%PCRXPacira BioSciences$24.96+0.2%3.6526 of 5 stars2.33$27.22 9.1%9Positive News2.83%HRMYHarmony Biosciences$33.20+0.0%4.4478 of 5 stars3.00$53.33 60.7%92.61%AMPHAmphastar Pharmaceuticals$29.02+2.1%4.3817 of 5 stars2.00$43.50 49.9%32.27%ARVNArvinas$7.05-7.1%3.6178 of 5 stars2.67$35.50 403.6%15Short Interest ↓Gap DownHigh Trading Volume1.98%SUPNSupernus Pharmaceuticals$32.78+1.5%2.7578 of 5 stars2.33$36.00 9.8%3Short Interest ↓1.94%ANIPANI Pharmaceuticals$67.52-0.1%3.785 of 5 stars3.00$79.75 18.1%9Positive News1.88%HROWHarrow$26.33+0.5%2.4862 of 5 stars3.00$61.50 133.6%4Earnings ReportAnalyst ForecastPositive NewsGap Down1.72%LGNDLigand Pharmaceuticals$104.62-2.8%4.4681 of 5 stars3.00$147.00 40.5%6Short Interest ↑Positive News1.69%LQDALiquidia$14.84-1.7%2.5623 of 5 stars3.11$26.63 79.5%91.69%COLLCollegium Pharmaceutical$29.91+0.7%4.0462 of 5 stars2.80$43.60 45.8%51.42%INVAInnoviva$18.11-0.4%4.4405 of 5 stars3.00$55.00 203.7%2Positive News1.34%WVEWave Life Sciences$8.36-3.1%4.5438 of 5 stars3.00$22.60 170.5%10Analyst RevisionGap Down1.30%AMRXAmneal Pharmaceuticals$8.42+1.6%3.2542 of 5 stars3.00$10.80 28.3%5Positive News1.02%EOLSEvolus$12.02-0.3%3.7893 of 5 stars3.00$24.67 105.3%41.00%MNMDMind Medicine (MindMed)$6.06-2.2%2.0354 of 5 stars3.23$25.11 314.6%13Gap Down0.97%OCULOcular Therapeutix$7.40-2.3%3.4641 of 5 stars2.88$16.38 121.2%80.95%XERSXeris Biopharma$5.51-1.3%3.8739 of 5 stars2.80$6.10 10.8%50.88%OMEROmeros$8.20-3.2%3.5682 of 5 stars2.80$22.50 174.6%5News Coverage0.74%ESPREsperion Therapeutics$1.46-3.0%3.781 of 5 stars2.50$6.75 363.9%6Analyst Revision0.73%CRMDCorMedix$6.18-8.4%2.5974 of 5 stars3.13$15.14 145.2%8Earnings ReportAnalyst RevisionGap Down0.67%NUVBNuvation Bio$1.76-3.6%1.9778 of 5 stars3.25$8.75 398.6%40.65%ELVNEnliven Therapeutics$19.79-6.1%2.6477 of 5 stars3.20$38.75 95.9%5Gap Up0.64%EYPTEyePoint Pharmaceuticals$5.46-6.3%1.8343 of 5 stars3.00$26.63 387.6%9Positive NewsGap Down0.52%PAHCPhibro Animal Health$21.42-0.2%3.8047 of 5 stars1.50$21.00 -1.9%4Short Interest ↓Positive NewsGap Down0.47%ZVRAZevra Therapeutics$7.50-4.5%2.7871 of 5 stars3.11$22.29 197.3%9Gap Up This page (NYSEARCA:XPH) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
